Experience of Having Chronic Graft-Versus-Host Disease
The Experience of Having Chronic Graft-Versus-Host Disease
1 other identifier
observational
187
1 country
2
Brief Summary
Primary Objectives:
- 1.To explore the experience of chronic graft-versus-host disease (cGVHD) following allogeneic blood or marrow transplantation from the perspective of the patient and the patient's primary family caregiver.
- 2.To develop and validate an instrument to measure the severity of multiple symptoms and the impact of these symptoms on daily functioning in patients who have cGVHD.
- 3.To develop a detailed description of the experience of having cGVHD.
- 4.To develop a detailed description of the symptom experience of cGVHD to allow for development of a symptoms instrument for cGVHD.
- 5.To assess the understanding of questions to measure the symptoms of cGVHD in patients with various levels of education.
- 6.To develop a detailed description of caring for a patient with cGVHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2006
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 13, 2006
CompletedFirst Posted
Study publicly available on registry
July 17, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedJuly 30, 2012
July 1, 2012
3.9 years
July 13, 2006
July 27, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phase 1: Open-Ended Interview/Questions designed to elicit specific descriptions of experience of having cGVHD or caring for a patient with cGVHD
At time of treatment, duration approximately 30 minutes
Study Arms (3)
Patients
Patients with chronic GVHD
Content Expert Panel
Content expert panel with 5 years experience caring for patients with cGVHD.
Caregivers
Caregivers of patients with cGVHD
Interventions
30-minute interviews of participating patients and their caregiver(s).
Questionnaires that will take approximately 5 minutes to complete.
Eligibility Criteria
Study participants with chronic graft-versus-host disease (cGVHD) following allogeneic blood or marrow transplantation, the patient's primary family caregiver, and content expert panel.
You may qualify if:
- years of age or older
- Ability to speak and read English
- Clinical or histological diagnosis of active cGVHD or at least 3 months post allogeneic BMT without a diagnosis of active GVHD (PATIENT ONLY)
- Identification as the single primary family caregiver by a patient with cGVHD (CAREGIVER ONLY)
- Physician or nurse with at least 5 years experience caring for patients with cGHVD (PROFESSIONAL EXPERT ONLY)
- At least one publication in the last 5 years dealing with cGVHD (PHYSICIAN PROFESSIONAL EXPERT ONLY)
- Consent to participate
You may not qualify if:
- Inability to understand the intent of the study
- Medical condition that would preclude participation in an interview lasting 30 minutes (PHASE 1 OF STUDY ONLY)
- Diagnosis of active psychosis or severe cognitive impairment
- Bone marrow or stem cell donor for patient (CAREGIVER ONLY)
- Disease for which BMT was performed not in remission (PATIENT ONLY)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Loretta A. Williams, DSN
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2006
First Posted
July 17, 2006
Study Start
February 1, 2006
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
July 30, 2012
Record last verified: 2012-07